These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Tetta C; Cavaillon JM; Schulze M; Ronco C; Ghezzi PM; Camussi G; Serra AM; Curti F; Lonnemann G Nephrol Dial Transplant; 1998 Jun; 13(6):1458-64. PubMed ID: 9641176 [TBL] [Abstract][Full Text] [Related]
3. In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines. Nagaki M; Hughes RD; Keane HM; Lau JY; Williams R Circ Shock; 1992 Nov; 38(3):182-8. PubMed ID: 1292881 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study on continuous plasma filtration absorption treatment for burn sepsis]. Meng A; Ren Y; Yang L; He L; Zeng S; Liu Q Zhonghua Shao Shang Za Zhi; 2014 Aug; 30(4):310-4. PubMed ID: 25429809 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model. Li M; Xue J; Liu J; Kuang D; Gu Y; Lin S Ther Apher Dial; 2011 Feb; 15(1):98-108. PubMed ID: 21272259 [TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
7. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns. Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020 [TBL] [Abstract][Full Text] [Related]
9. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Rimmelé T; Assadi A; Cattenoz M; Desebbe O; Lambert C; Boselli E; Goudable J; Etienne J; Chassard D; Bricca G; Allaouchiche B Nephrol Dial Transplant; 2009 Feb; 24(2):421-7. PubMed ID: 18799607 [TBL] [Abstract][Full Text] [Related]
10. [Plasma contents of cytokines (TNF-alpha, IL-1 beta, IL-6) and their clearance during continuous hemofiltration in patients with sepsis and multiple organ failure]. Timokhov VS; Iakovleva II; Kalashnikova EA; Ipat'eva EI Anesteziol Reanimatol; 1997; (3):59-62. PubMed ID: 9289991 [TBL] [Abstract][Full Text] [Related]
11. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813 [TBL] [Abstract][Full Text] [Related]
14. Blood and plasma treatments: the rationale of high-volume hemofiltration. Honoré PM; Joannes-Boyau O; Gressens B Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149 [TBL] [Abstract][Full Text] [Related]
15. Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation? Joannes-Boyau O; Honore PM; Boer W; Collin V Nephrol Dial Transplant; 2009 Feb; 24(2):354-7. PubMed ID: 19054800 [No Abstract] [Full Text] [Related]
16. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. Gogos CA; Drosou E; Bassaris HP; Skoutelis A J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Kaneyama K; Segami N; Sun W; Sato J; Fujimura K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832 [TBL] [Abstract][Full Text] [Related]
18. [Effect of continuous veno-venous hemofiltration on the plasma level of cytokines in patients with multiple organ dysfunction syndrome]. Kou QY; Chen J; Ouyang B; Guan XD Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1197-9. PubMed ID: 17147866 [TBL] [Abstract][Full Text] [Related]
19. Transfer of endogenous pyrogens across artificial membranes? Lonnemann G; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1998 May; 66():S43-6. PubMed ID: 9573572 [TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation. Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]